Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
[forminator_form id="25163"]

Microsoft's AI diagnostic system correctly solved 83% of complex New England Journal of Medicine cases in a simulation. Generalist physicians using reference materials got 36% right, according to a study published Thursday, October 22, in Science. Microsoft AI CEO Mustafa…

QIAGEN has agreed to be taken private by EQT in an all-cash deal. The buyout firm's EQT XI fund will offer €46.50 per share, a 40.3% premium to the Dutch-domiciled diagnostics company's unaffected share price, the companies said on October…

The FDA on Tuesday granted Emergency Use Authorization to OraSure Technologies for its OraQuick Ebola 2.0 Rapid Antigen Test, a second-generation diagnostic capable of detecting the Bundibugyo virus driving the current Ebola epidemic in Central Africa.